Risk of transfusion-transmitted Babesia microti in Canada.

Sheila F O'Brien Steven J DrewsQi-Long YiEvan M BlochNicholas H OgdenJules K KoffiLeslie Robbin LindsayYves GregoireGilles Delage

Published in: Transfusion (2021)

The likelihood of clinically relevant TTB is low. Testing would have very little utility in Canada at this time. Ongoing pathogen surveillance in tick vectors is important as B. microti prevalence appears to be slowly increasing in Canada.

Keyphrases

public health
cardiac surgery
acute kidney injury
sickle cell disease
gene therapy